47
Growth Score
pts
Heat Score
1 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
See more interactive data and historical milestones on desktop for the best experience
3418157
Spinraza treats spinal muscular atrophy (SMA) in pediatric and adult patients through intrathecal injection.
About the Company
Spinraza is a prescription medicine used to treat spinal muscular atrophy (SMA) in pediatric and adult patients. It is administered through intrathecal injection and has shown meaningful improvements in motor function in clinical trials. The treatment requires a healthcare provider to complete the necessary forms and monitor the patient for
potential side effects, including serious adverse events like atelectasis. Spinraza is designed to address the underlying genetic cause of SMA by increasing the production of survival motor neuron (SMN) protein.
